Treatment of spasticity with botulinum toxin: A double‐blind study
- 8 October 1990
- journal article
- clinical trial
- Published by Wiley in Annals of Neurology
- Vol. 28 (4), 512-515
- https://doi.org/10.1002/ana.410280407
Abstract
We studied the effect of botulinum‐A toxin on spasticity of the leg adductors in 9 patients who were either chair‐bound or bed‐bound with chronic stable multiple sclerosis. We injected botulinum toxin (400 mouse units) or placebo into the adductor muscles in a randomized, crossover, double‐blind design. Two physicians, who were unaware of the treatment order, used an objective rating scale and independently assessed the patients; interobserver correlation was excellent (r = 0.93‐0.81). We found that botulinum toxin produced a significant reduction in spasticity (p = 0.009) and a significant improvement in the ease of nursing care(p = 0.009). There were no adverse effects during this shortterm trial. This is the first demonstration of the beneficial effect of botulinum toxin on focal spastic muscle contractions.Keywords
This publication has 11 references indexed in Scilit:
- Intrathecal Baclofen for Severe Spinal SpasticityNew England Journal of Medicine, 1989
- Effects of botulinum toxin injections on speech in adductor spasmodic dysphoniaNeurology, 1988
- Botulinum toxin in spasmodic torticollis.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Local Treatment of Spasmodic Torticollis with Botulinum ToxinCanadian Journal of Neurological Sciences, 1987
- DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLISThe Lancet, 1986
- Blepharospasm, Meige syndronfie, and hemifacial SpasmNeurology, 1985
- Botulinum A Toxin Injection as a Treatment for BlepharospasmAmerican Journal of Ophthalmology, 1985
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- SpasticityNew England Journal of Medicine, 1981
- Botulinum Toxin: Mechanism of Presynaptic BlockadeScience, 1976